News: Teva Gets FDA Warning Letter for Jerusalem Plant

Teva Pharmaceutical Industries has been notified in a warning letter of weaknesses at its Jerusalem oral solid dosage plant (OSD) after an inspection last year by the U.S. Food and Drug Administration.